Bio-Rad to Present Company Overview at J.P. Morgan 41st Annual Healthcare Conference
January 04 2023 - 9:00AM
Business Wire
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader
in life science research and clinical diagnostic products, today
announced that Norman Schwartz, President and CEO, will present a
company overview at the 41st Annual J.P. Morgan Healthcare
Conference on Tuesday, January 10, 2023, at 4:30 p.m. Pacific Time.
The presentation will be followed by a Q&A session with
participation from Bio-Rad’s Executive Vice President and COO
Andrew Last, and Executive Vice President and CFO Ilan Daskal.
A link to a live webcast of the event will be accessible in the
Investor Relations section of Bio-Rad’s website at bio-rad.com.
About Bio-Rad
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) is a global
leader in developing, manufacturing, and marketing a broad range of
innovative products for the life science research and clinical
diagnostic markets. With 70 years of focus on quality and customer
service, our products advance the scientific discovery process and
improve healthcare. Our customers are universities, research
institutions, hospitals, biotechnology and pharmaceutical
companies, as well as public health and commercial laboratories
including food safety and environmental quality testing facilities.
Based in Hercules, California, Bio-Rad has a global network of
operations with approximately 8,200 employees worldwide and $2.9
billion in revenues in 2021. For more information, please visit
bio-rad.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230104005135/en/
Investor Contact: Edward Chung, Investor Relations
510-741-6104 ir@bio-rad.com
Media Contact: Anna Gralinska, Corporate Communications
510-741-6643 cc@bio-rad.com
Bio Rad Laboratories (NYSE:BIO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Bio Rad Laboratories (NYSE:BIO)
Historical Stock Chart
From Sep 2023 to Sep 2024